Literature DB >> 9626843

Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators.

M Zabalgoitia1, J L Halperin, L A Pearce, J L Blackshear, R W Asinger, R G Hart.   

Abstract

OBJECTIVES: This study explored the mechanisms linking clinical and precordial echocardiographic predictors to thromboembolism in atrial fibrillation (AF) by assessing transesophageal echocardiographic (TEE) correlations.
BACKGROUND: Clinical predictors of thromboembolism in patients with nonvalvular AF have been identified, but their mechanistic links remain unclear. TEE provides imaging of the left atrium, its appendage and the proximal thoracic aorta, potentially clarifying stroke mechanisms in patients with AF.
METHODS: Cross-sectional analysis of TEE features correlated with low, moderate and high thromboembolic risk during aspirin therapy among 786 participants undergoing TEE on entry into the Stroke Prevention in Atrial Fibrillation III trial.
RESULTS: TEE features independently associated with increased thromboembolic risk were appendage thrombi (relative risk [RR] 2.5, p = 0.04), dense spontaneous echo contrast (RR 3.7, p < 0.001), left atrial appendage peak flow velocities < or = 20 cm/s (RR 1.7, p = 0.008) and complex aortic plaque (RR 2.1, p < 0.001). Patients with AF with a history of hypertension (conferring moderate risk) more frequently had atrial appendage thrombi (RR 2.6, p < 0.001) and reduced flow velocity (RR 1.8, p = 0.003) than low risk patients. Among low risk patients, those with intermittent AF had similar TEE features to those with constant AF.
CONCLUSIONS: TEE findings indicative of atrial stasis or thrombosis and of aortic atheroma were independently associated with high thromboembolic risk in patients with AF. The increased stroke risk associated with a history of hypertension in AF appears to be mediated primarily through left atrial stasis and thrombi. The presence of complex aortic plaque distinguished patients with AF at high risk from those at moderate risk of thromboembolism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626843     DOI: 10.1016/s0735-1097(98)00146-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  109 in total

1.  Three dimensional flow in the human left atrium.

Authors:  A Fyrenius; L Wigström; T Ebbers; M Karlsson; J Engvall; A F Bolger
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

2.  [Persistent left atrial thrombus in atrial fibrillation under oral anticoagulation].

Authors:  B Leithäuser; F Kasch; T Broemel; J-W Park
Journal:  Herz       Date:  2010-12       Impact factor: 1.443

Review 3.  Atrial fibrillation: the most common arrhythmia.

Authors:  C R Wyndham
Journal:  Tex Heart Inst J       Date:  2000

Review 4.  Transesophageal echocardiography and stroke.

Authors:  Timothy D Woods
Journal:  Curr Atheroscler Rep       Date:  2005-07       Impact factor: 5.113

Review 5.  Identification, diagnosis and assessment of atrial fibrillation.

Authors:  R I Dewar; G Y H Lip
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

6.  The application of vWF/ADAMTS13 in essential hypertension.

Authors:  Wei-Hong Ma; Lin Sheng; Hui-Ping Gong; Lin-Lin Guo; Qing-Hua Lu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

7.  [European Stroke Organisation 2008 guidelines for managing acute cerebral infarction or transient ischemic attack. Part 1].

Authors:  P Ringleb; P D Schellinger; W Hacke
Journal:  Nervenarzt       Date:  2008-08       Impact factor: 1.214

8.  Interactions between cardiovascular and cerebrovascular disease.

Authors:  Giuseppe Di Pasquale; Stefano Urbinati; Enrica Perugini; Simona Gambetti
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

9.  Percutaneous isolation of left atrial appendage thrombus.

Authors:  Oh-Hyun Lee; Jae-Sun Uhm; Jung-Sun Kim; In-Jeong Cho; Geu-Ru Hong; Hui-Nam Pak; Yangsoo Jang
Journal:  J Cardiol Cases       Date:  2017-06-16

Review 10.  [Stroke prophylaxis in atrial fibrillation : When, how and for whom?]

Authors:  T Maurer; C Sohns
Journal:  Herz       Date:  2017-06       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.